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7INTRODUCTION
`The birth of an neonate to the painfree parturient  will be the most
rewarding moment in Obstetric practice.’ The most painfull experience in
a woman s life is labour. Quite unbearable is the pain of child birth and its
related agony at times is beyond description.’
The mother of yesterday is no more the mother of today”.
Complex,psycological,physiological interactions are involved in labour.
Multiple system like gastrointestinal, cardiovascular, respiratory, genito
urinary, neuro endocrine may be affected if pain not adequately
controlled, blood flow to the placenta which may be reduced due to pain
lead to altered fetal homeostasis. These consequences are avoidable by
effective analgesia during labour.
There are several methods   that can be employed in labour pain
control like intravenous anesthesia’ opiod analgesics local anesthetics
inhalational anesthetics regional anesthetics, lumbar epidural analgesics
The most effective and least depressant treatments for labor pain are the
neuraxial techniques allowing for an alert and participating mother
[ACOG].
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8The American College of Obstetricians and Gynecologists [2006]
and the American Society of Anesthesiologists issued  a joint statement
on labour pain that  in the absence of medical contraindication ‘ maternal
request is sufficient justification for analgesia during labour .’
NEONATAL AND FETAL BENEFIT
In comparison to opiod analgesia neuraxial techniques have good
Apgar Score and  decreased  incidence of metabolic acidosis.
Epidural analgesia is preferred since
1. Neonatal respiratory depression is reduced wherein the
intramuscular opioid have been repeated.
2. In the conditions where the fetus is already compromised like
pregnancy induced hypertension, intra uterine growth restriction.
3. Improvement in uteroplacental blood flow and opioid effects are
limited.
4.  To  assist  the  premature,  breech  or  multiple  pregnancy  with  a
controlled birth.
BENEFIT IN MOTHER
1. As an adjunct to antihypertensive therapy in severe pre eclampsia.
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92. To stabilise blood pressure In cardiac, respiratory, neuromuscular
and neurological disease of women may have significant safety
benefits with pain control.
3. Women who have significant risk factors like difficult airway
management morbid obesity who have significant anesthesia risk
related to general anesthesia
CONTRAINDICATIONS
1. Infection at local site or systemic sepsis.
2. There is an increased risk of epidural or spinal haematoma with
defective haemostasis e.g. severe Thrombo cytopenia;
frankcoagulopathy; disorders of blood factors, Heparin or Aspirin
taken recently,  the count of platelets and the test related to their
function coagulation profile   are checked.
3. Severe preeclamptic women  with abruption, inherited disorders of
bleeding  recently taken anticoagulant treatment.
4. Uncorrected hypovolaemia
5. Intracranial tension with mass lesion.
6. If one cannot guarantee an aseptic technique.
7. Refusing or withdrawing of consent of the women
8. Inadequately trained of staff.
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HISTORY
Child birth is considered a painful process and there are associated
myths and controversies about pain relief during labour.
People believed the birthing  process is painful and  interference
not needed.
Several methods in the earlier days used to relieve labour pain.
Various non- pharmacological and pharmacological methods in the
modern era are being practiced for labour analgesia and the use of labour
analgesia had gained its popularity.
For labour analgesia, the most frequently employed
pharmacological methods are neuraxial analgesia, systemic opiod
analgesia, inhalational analgesia.
Labour analgesia has undergone extensive research in the last four
decades to find an ideal labour analgesia safe to both mother and the in
utero fetus.
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History of development in labour analgesia
Ether in 1847
Chloroform in 1853
Nitrous Oxide in1881
Spinal with Cocaine in 1990
Morphine and Hyoscine in1902
Caudal Epiduralin 1909
Sacral Epidural in 1930
Pethidine in 1940
Continuous Caudal Epidural in 1943
Continuous Lumber Epidural in 1949
Psycho prophylaxis by Lamaze in 1959
TENS in 1980
The criteria for the  Ideal technique of labour analgesia
 Any drug or technique used in labour analgesia should be simple,
safe and must have high technical success rate. It should be acceptable to
mother and allow her active participation in the labour process. These
drugs and or techniques should provide complete analgesia throughout
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the painful period of labour and must be devoid of any harmful effect on
mother and labour process. Complete fetal homeostasis should be
maintained without any depressant effect on fetus.
Physiology of Labor Pain
 During the first stage of labour, pain impulses arise primarily from
the uterus. Uterine contractions may result in myometrial ischemia, which
ultimately causes the release of bradykinin, histamine, and serotonin. In
addition, stretching and distention of the lower uterine segment and
cervix may stimulate mechanoreceptors. These noxious impulses
transmitted via A delta and C fibres follow the sensory nerve fibers that
accompany sympathetic nerve endings; they travel through the
paracervical region and the hypogastric plexus to enter the lumbar
sympathetic chain.
Central connections to the spinal cord is via the dorsal root
ganglion and lateral division of posterior roots.These stimuli enter the
spinal cord at the T10, T11, T12, and L1 spinal segments.
Pain is referred to the area of skin supplied by these nerves.
Parturients describe this pain as dull in nature(visceral) and often
poorly localized in the lower abdomen, loin and lumbosacral region.
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13
With  onset  of  the  second  stage  of  labour  and  stretching  of  the
perineum, somatic afferent nerve fibers transmit impulses through the
pudendal to the spinal cord at the S2, S3, and S4 levels  :
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
14
Pain scores using the  McGill Pain Questionnaire comparison
Mechanism of Labor Pain
Pain Pathway in first stage
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Mechanism of Labor Pain in Second Stage
Activation of the same afferents Adelta and C fibres activated
during the first stage of labour plus afferents that innervate the vaginal
surface of the cervix, the vagina, and the perineum. Afferents course
through the pudendal nerve with DRG at S 2-S4, and they are somatic in
nature.  Hence analgesia should cover dermatomes L2to S5.
First stage pain is visceral best relieved by narcotics and second
stage pain is  Somatic nature best relieved by local anesthetics.
Hence  neuraxial technique using  Local anesthetic with narcotic in
low doses most versatile techniques of pain relief.
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PAIN PATHWAYS DURING LABOUR PAIN IN LABOUR
Site of Origin Cause Pathway Site of Pain
Uterus and
cervix
Contraction and
distension of uterus
and dilatation of
cervix
Afférent T10 –
L1
Post. Rami T10 –
L1
Upper abdomen to
groin, mid back
and inner upper
thighs (referred
pain)
Peri-uterine
tissue (mainly
posterior)
Pressure often
associated with
occipito posterior
position and flat
sacrum
Lumbo sacral
plexus
L5- S1
Mid and lower
back and back of
thighs (referred
pain)
Lower birth
canal
Distension of vagina
and perineum in
second stage
Somatic roots
S2- S4
Vulva, Vagina and
Perineum
Bladder Over distension Sympathetic
T11-L2
Parasympathetic
S2-S4
Usually
suprapubic
Myometrium
and uterine
visceral
peritonium
Abruption
Scar dehiscence
T10-L1 Referred Pain to
site of pathology
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EFFECTS OF LABOR PAIN ON MOTHER
Obstetric Course
? Neural  stimulation through pain pathways results  in the release of
substances that either drive (oxytocin) or brake (epinephrine)
uterine activity and cervical dilation; effect of analgesia on the
course of labor can vary between individuals.
Cardiac and Respiratory Effects
? The intermittent pain of uterine contractions also stimulates
respiration and results in periods of intermittent hyperventilation.
In the absence of supplemental oxygen administration,
compensatory periods of hypoventilation between contractions
result in transient periods of maternal hypoxemia and, in some
cases, feta hypoxemia.
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
18
PSYCHOLOGICAL EFFECTS
Small proportion of women can be psychologically harmed by
either providing or withholding analgesia
Both individual and environmental influences upon this meaning.
Effects of labor pain on fetus
Labor pain affects multiple systems that determine utero-placental
perfusion:
(1) uterine contraction frequency and intensity, by the effect of
pain on the release of oxytocin and epinephrine;
(2) uterine artery vasoconstriction, by the effect of pain on the
release of norepinephrine and epinephrine; and
(3) maternal oxyhemoglobin desaturation, which may result
from intermittent hyperventilation followed by
hypoventilation.
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TECHNIQUES OF LABOUR PAIN RELIEF
Non pharmacological
1. Psycho prophylaxis
2. Hypnosis
3. TENS
4. Acupuncture and Acupressure
5. Hydro therapy
6. Miscellaneous
7. Yoga Music therapy
8. Breathing exercise
Pharmacological
1. Inhalation analgesia N2O:O2, Ether, trilene Halogenated
compounds like Enflurane, isoflurane, sevoflurane.
2. Parenteral analgesia Opioids: pethidine, pentazocine, fentanyl,
Remifentanil, sufentanil,  meperidine, butorphanol and
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nalbuphine. Non-opioid: tramadol Sedative & tranquiliser:
diazepam, midazolam Ketamine.
3. Regional analgesia Lumbar epidural Caudal epidural Spinal
analgesia Combined spinal-epidural Walking epidural Patient
controlled epidural analgesia
4. Paracervical block
Hydrotherapy involve a simple shower or tub bath, or it include
the use of a whirlpool or large tub specially equipped for pregnant
patients.  Benefits of hydrotherapy includes reduced pain & anxiety,
decreased BP & increased efficiency of uterine relaxation.
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AIMS AND OBJECTIVES
The study aim  is to analyse the maternal and perinatal outcome of
obstetric analgesia during labour. The study also compares with outcomes
of those who did not receive analgesia. The study was conducted at
Institute of Social obstetrics and government Kasturba Gandhi hospital
Chennai from the period of November 2012 to November 2013.
OBJECTIVES
 To  study  the  effects  of  obstetric  [epidural]  analgesia  in  the
following aspects  :
1. Effectiveness of pain relief in terms of maternal comfort
satisfaction.
2. Duration of labour its influence on all three stages and the
initiation of analgesia to delivery interval.
3. Mode of delivery –spontaneous vaginal instrumental and LSCS.
4. Maternal complications like hypotension, pyrexia, backache,
headache, bladder dysfunction and third stage complication like
retained placenta, PPH, urinary retention.
5. Neonatal outcome in the form of Apgar scores intrapartum post
partum and early neonatal complications and birth weight.
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REVIEW OF LITERATURE
The term Natural Childbirth coined by Grantly Dick Read in 1933
who believed child birth was painless and no intervention needed if
women prepared.
Fernard Lamaze French obstetrician adapted the Russian Pavlovian
methods in 1950 focussed on teaching mother conditioned reflexes to
overcome pain and fear of child birth which included breathing exercises
relaxation techniques and human support.
Religious taboos resulted in centuries of denial of pain relief.
Fifteen century midwives were burned at the stake for offering pain relief
in labour.
The modern era of obstetric analgesia began in 1847 when James
Young Simpson a Scottish obstetrician administered ether to a women
with rickety pelvis in labour.
Charles Dmeigs Philadelphia obstetrician believed Labour pain has
a purpose uterine pain inseparable from contractions and any drug
abolishes pain will alter contractions.
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23
John Snow [1853) administered chloroform to Britain Queen
Victoria during birth of eight and ninth child.
Pain in labour is a complex subjective interaction of physiological
psychological and socio cultural factors on women individual
interpretation of labour stimuli [Donald et al 2002].
Melzack [1984] used a questionnaire to assess the intensity and
emotional impact of pain [McGill pain rating index]. In  nulliparous
labour pain rated as digit amputation [without anesthesia].
Penny and O Hara [2002] systematically reviewed non
pharmacological methods of pain relief as inexpensive quality may be
poor and no scientific validity.
Henneborm and Cogan [1975] noted continuous labour support
decreased maternal anxiety and medication requirements.
Kennel and colleaques [1991] showed lower level of caesarean
section in women who had emotional support through labour.
 Minnich et al [2004] showed touch and massage transmits sense of
security and wellbeing.
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Melzack et al 1991 Bloom et al 1998 studied various postures on
pain perception and outcome of labour vertical position to horizontal
position.
Bloom and colleaques [1998] found walking did not have effect on
labour.
A  review  by  Downswell  and  colleques  [2009]  there  is  little
difference in pain ratings between TENS[trans cutaneous electric nerve
stimulation] TENS decreased pain and no evidence that TENS had impact
on intervention and outcomes of labour.
Belfrage et al 1981 studied infants born within the period of
maximum fetal uptake of pethidine [ie 2-3 hrs after maternal
administration] had increased risk of respiratory depression.
Sosa and co workers [2004] in a randomised controlled trial
concluded pethidine not to be given in parturients with cervical dystocia.
Chest nut et al[2009]: Fentanyl highly lipid soluble opiod has
analgesic potency 100 times of morphine and 800 times of pethidine. It
has rapid onset, short duration of action, no major metabolities, no effect
on Apgar scores or neurobehavioral scores at 2and 24 hrs.
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Douma et al [2009] studied the efficacy of patient controlled
pethidine fentanyl remifentanyl for labour analgesia Remifentanyl PCA
provided better analgesia than the rest.
Rosen et al [2002] reviewed Entonox a mixture of 50% oxygen and
50% nitrous oxide for labour not potent analgesic but not interfere with
uterine activity and neonatal Apgar.
Hart et al [2003] currently advocates a low dose mixture of local
anesthetics with lipophilic narcotic.
Bupivacaine economical and effective as newer agents [Atienzaret
al 2008].
Leighton and Halpern [2002] that epidural not increase caesarean
rates.
Liu and Sia [2004] low concentration of bupivacaine unlikely to
increase caesarean rates.
Liberman and O Donaghue [2002]had evidence to conclude
epidural associated with lower spontaneous delivery higher instrumental
vaginal and longer labour prolonged second stage but does not affect
neonatal outcome in nulliparous.
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 Liu and sia [2004] and Anim-Somuah [2005]found epidural
increases instrumental delivery but not caesarean and not associated with
low Apgar at 5 min and not affect lactation [Cochrane Database
systematic review 2005].
Torvaldsen et al [2004] concluded larger studies required to
determine discontinuing epidural late in labour decreases instrumental
delivery.
People [pushing Early or Pushing Late with Epidural ] trial Fraser
et al 2000 showed delayed pushing for maximum 2 hrs compared with
immediate pushing at full dilatation in nullipara with epidural analgesia
showed significant reduction in incidence of difficult births [22.5% to
17.8%].
Hansen et al [2002] found no difference in outcomes in
multiparous who waited for one hour before pushing.
 Buxton et al [1988] Robert et al 2003]showed policy of delayed
rather early pushing for women with epidural analgesia reduced operative
intervention at the expense of increased second stage duration.
 Maltau and Anderson 1975 Schnider et al 1983 Desai et al 2006
studied  that epidural analgesia may accelerate an already prolonged and
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exhausting labour and reduce caesarean for failure to progress. Effective
analgesia reduces inhibitory effect of endogenous catacholamines on
uterine contractility attenuates acidosis and permits to tolerate oxytocin
augmentation.
PEOPLE trial [Franser e all 2000] nullipara with analgesia waiting
up to 2 hrs before pushing results in reduction in median duration of
active pushing [from 110 min to 68 min].
Simpson and James [2005] and Hansen et al [2002]reported fewer
incidence for fetal heart rate decelerations in primi and multi who waited
befare pushing.
Franser et al [2000] showed lower umbilical cord PH in infants of
delayed pushing group.
Menticoglou et al [1995] studied 93 % of nullipara with epidural
analgesia delivered in 4 hrs of full diatation 7% second stage more than 4
hrs less than one third had spontaneous vaginal delivery .No change in
neonatal outcome.
Cheng et al 2004 2007 reported when second stage longer than 4
hrs  studied increase  in maternal morbidity like post partum haemorrhage
third and fourth degree lacerations, operative vaginal birth and caesarean.
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Sleep [1990] adverse outcome of prolonged second stage may be
due to underlying causative factor and not on absolute duration.
Bates et al [1985] labour epidural analgesia had more descent
disorders and high operative vaginal than who not received which may be
due to interference to beardown reflex and inability to push.
 Halpern et al [1998] did a metaanalysis of 2400 women assigned
epidural analgesia or  parenteral analgesia that epidural prolonged active
phase by 42 min and second stage by 14 min.
Thorp et al 1993 showed significant caesarean rate increase
whereas Sharma et al 2002 showed no differences.
Yuong strom et al 1996 used low dose anesthetics like bupivacaine
with opioidagonist fentanyl with minimal motor block and preservation
of urge to push.
 Kilpatrick and laros [1989] found 95 th percentiles for second
stage in nullipara with analgesia 185 min and without 132 min and in
multipara 61 and 85 min Anim- Somuah and colleaques [2005] reviewed
Cochrane database showed incidence of long term back ache similar
between women receiving labour analgesia and who did not.
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 COMET group study has demonstrated reduced instrumental
vaginal delivery with the   ‘mobile’ epidurals with the  low dose neuraxial
techniques with an opiod as adjuvants  will reduce pain transmission in an
additive or synergistic fashion will effectively provide analgesia  with
proven safety and efficacy and without much unwanted side effects.
 Epidurally administered clonidine and neostigmine  that are
promising more recently.
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MATERIALS AND METHODS
This  study  was  carried  out  in  70  women who were  admitted  with
labour pain for safe confinement in the department of Obstetrics and
gynecology at Institute of Social Obstetrics and Government
Kasturba Gandhi Hospital, Chennai during the period  October 2012 to
November 2013.
Study Design : Descriptive case study
Institutional ETHICAL COMMITTEE Clearance obtained
Methodology
70 Pregnant women who received epidural analgesia in labour
were  enrolled  in  this  study.  The  patients  with  similar  profile  as  study
group were enrolled as control groups.
Inclusion criteria
1. Women with gestational age more than 37 weeks maturity
confirmed by Ultra sound in established labour with regular uterine
contractions ( 3 -4 in 10 minutes lasting 45 seconds) with cervical
effacemet more than 50 % and dilatation > 3 cms with cephalic
presentation.
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2. Age > 18 years < 35 years.
3. Height >145 – 160 cms.
4. Weight 50 -65 Kgs.
5. No fetal distress.
Exclusion criteria
1. Patient refusal
2. Known case of allergic reaction to local anesthetics
3. Women with cephalo pelvic disproportion and contracted
pelvis and Malpresentation
 4. Coagulation problems and thrombocytopenia
 5. Aspirin within 3 days Platelets less than 80000
 6. Severe Preeclampsia-abruption HELP Syndrome
7.  Placenta previa with hemodynamic instability
 8. Severe Anemia
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Preparation
? The patient requests epidural analgesia for pain relief (or for relief
of anticipated pain, planned induction of labor).
? Preanesthetic evaluation, which includes an assessment of the
patient's medical obstetric and anesthetic history.
?  The risks of epidural analgesia are discussed with the patient, and
written informed consent is obtained.
? And the procedure explained, all relevant obstetric issues are
understood (e.g., gestational age, intrauterine growth restriction,
fetal presentation, risk of obstetric hemorrhage, previous cesarean
delivery).
? An assessment of fetal well-being is performed .
Maternal blood pressure monitoring from initiation of epidural
every 5 min for first 20 to 30 min and after every dose.
NICE guidelines recommend the continuous electronic fetal
monitoring during establishment of epidural analgesia.
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
33
Resuscitation Drugs
? Thiopental
? Succinylcholine
? Ephedrine
? Atropine
? Epinephrine
? Phenylephrine
? Calcium chloride
? Sodium bicarbonate
? Naloxone
EQUIPMENT
? Oxygen supply
? Self-inflating bag and mask for positive-pressure ventilation
? Masks
? Oral and nasal airways
? Laryngoscopes
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Parameters observed
Baseline maternal respiratory rate pulse rate blood pressure
saturation
Baseline visual analogue scale score
Base line fetal heart rate
Onset of pain relief
Degree of analgesia
Intensity of pain at 5 10 15 30 60 min after analgesia and every 30
min
Intensity of uterine contractions
Rate of cervical dilatation
Partogram to monitor progress of labour
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DRUG USED LOW DOSE  BUPIVACAINE 0.0625% WITH
OPIOD FENTANYL 25 MCG
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VARIOUS EPIDURAL DRUG REGIMES
Drug Intermittent injection Continuous infusion.
Bupivacaine 5-10 mL of a 0.125%-0.375% solution every 60-120
min 0.0625%-0.25% solution given at a rate of 8-15 mL/hr.
Ropivacaine 5-10 mL of a 0.125%-0.25% solution every 60-120
min 0.125%-0.25% solution given at a rate of 6-12 mL/hr.
Lidocaine 5-10 mL of a 0.75%-1.5% solution every 60-90 min.
0.5%-1.0% solution given at a rate of 8-15 mL/hr.
Epidural analgesia initiated by anesthetist.
Patient shifted to operation theatre.
Anesthesia machine checked emergency airway equipment
verified.
Intravenous access with 18 guage established.
Prolaoded with 10 ml/kg lactated ringers given.
Monitor maternal blood pressure every 5 min of bolus of local
anesthetic.
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Continuous fetal heart rate monitoring and continuous verbal
communication.
Equipment needed 17 guage tuohy needle and 19 guage epidural
catheter.
Patient in left lateral or sitting position strict asepsis followed.
Skin infiltration with 2% lignocaine1.5 ml tuohy needle entered via
l2-l3 interspinous space epidural space identified by loss of resistance to
air technique kept 3 cm inside .catheter firmly secured to back.
A test dose of 3 ml of 1.5 % lignocaine with 1 in 200000
epinephrine injected after aspiration and after a contraction to minimise
confusion of tachycardia due to pain aith tachycardia due to intravenous
injection of test dose.
Test dose negative 5 ml of .0625% bupivacaine injected to reach a
cephalad sensory level of T10.
After 15 min block assessed by loss of sensation to cold or
pinprick.Replace catheter in inadequate or asymmetrical block.
After observation of 30 min patient shifted to labour ward in left
lateral position to avoid aorta caval compression.
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Maternal recorded every 5 min and the fetal heart rate is monitored
continuously.
The level of analgesia assessed hourly.
Drug given on patient first request and only by anesthetist.
Parameters observed.
Onset of sensory loss.
Level of sensory loss.
Any motor block.
Uterine contractions rate of cervical dilatation.
Duration of labour all three stages.
Mode of delivery.
Fetal outcome
Fetal heart rate
Apgar score ot1 and 5 min
Patient comfort
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Analgesia for the first stage of labor is achieved when T10-Ll
dermatomes are blocked with a low concentrations of local anesthetic, in
combination with a lipid-soluble opioid.
In  the  second  stage  of  labor and delivery, the block should be
extended to include the pudendal segments, S2-4 to combat pain due to
vaginal distension and perineal pressure.
Complications
? Hypotension (Incidence 17-20%)
? Inadequate Analgesia (0.5-1.5%)
? Intravascular Injection of Local Anesthetic
? Unintentional Dural Puncture (1-7.6%)
? Unexpected High Block
? Subdural injection of a local anesthetic (0.82%)
? Extensive motor blockade
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WHY LABOUR ANALGESIA?
The labour pain during contraction produces a generalised
neuroendocrinal stress response and  a widespread physiological effects
in the first stage of labour like the increased oxygen consumption,
hyperventilation and the respiratory alkalosis; increased cardiac output,
systemic peripheral resistance and blood pressure; gastric emptying may
be delayed, impaired uterine contractility and diminished uterine
perfusion and metabolic acidaemia.
Other factors (such as anxiety, starvation and physical exertion) are
also responsible for some of these effects, pain appears to be the most
potent of them and effective epidural analgesia has the ability to obtunds
these effects. The increase in oxygen consumption and minute ventilation
that are  primarily due to pain.
Epidural analgesia decreases the work of breathing and the oxygen
consumption  in  both  the  first  and  second  stages  of  labour.   Instead  of
stopping these processes from happening, measures to be taken to
minimize the pain.
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PAIN THEORIES
Specificity Theory Rene Descartes, a French philosopher and
mathematician proposed a theory in the late 16th century found the
severity and intensity of pain felt was directly related to the severity and
intensity of the injury. For example, pricking the finger with a needle or a
pin produces minimal pain, while cutting the hand with a knife provides
more intense and severe pain. This theory is often considered one of the
"original" pain theories and is commonly accepted by most. This theory is
generally accurate when related to many injuries and the pain related to
these injuries. This theory can be related to birth, however, is less
commonly related to birth than the Gate Control Theory and the Fear
Tension Pain Cycle Theory.
Gate Control Theory The nerve fibers transmitting labour pain
sensations are unmyelinated and carry nerve impulses more slowly than
the nerve fibers that carry sensations of light pressure, soft touch and
vibration. Transmitting pleasurable impulses (like as light, soft touch),
will reach the brain first, and that can cause modulation, or interference
with, the pain sensations.
Merkel’s disks are nerve endings the sensations of which very
quickly transmitted to the brain. They are mostly located in the palms, the
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soles of the feet, and the lips. Thus, having partners to hold a parturient
hand, rub her feet, which can all help interrupt the pain sensations.
Parturients can also grip the rails of the bed, or stand up inorder to
activate some of these sensors.
Meissner’s corpuscles that are found in the fingertips, and
sensations from which of them are transmitted quickly.In general, sensory
input has the ability to distract us from pain perception.Therefore, any
sensory input the women finds pleasant and relaxing can help her
massaging , light touch, music, a focal point to look at, aroma therapy, so
on.
Ronald Melzack and Patrick Wall in 1960 recognized the
importance of the mind in relation to the perception of pain. This pain
theory is based on the fact that the experiencing pain relies on the
complicated interactions that exists between the central nervous system
and the peripheral nervous system. The signals thereafter travel through
the peripheral nerves to the brain., Melzack and Patrick labeled as "nerve
gates," that which before reaching the brain open or close due to various
circumstances. Therefore the "nerve gates" are open at the time when the
pain signals are sent, the signals can easily pass onto the brain, and the
pain is then felt intensely.
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Thereafter when the "nerve gates" are closed, the signals have
more difficulty passing through and pain felt is either incredibly lessened,
or eliminated. Certain factors that help to open or close the "nerve gates."
Factors that which open the "nerve gates," allowing pain signals to travel
more freely and easily, thus intensifying pain include;
Cognitive factors Being preoccupied and concerned with the pain
can open the gates making it easier for these signals to travel, thus
worsening pain. Having high levels of anxiety over the pain opens the
"nerve gates,
Sensory factors, such as being under the influence of drugs or
alcohol, as well as poor physical condition and lack of mobility may open
the "nerve gates" allowing pain signals to travel more freely.
Emotional factors can impact the "nerve gates" just as much, if
not more than cognitive and sensory factors. Individuals suffering from
depression, or anxiety are more likely to have open "nerve gates." If the
individual is incredibly fearful, and feels helpless when it comes to the
pain, the gates are much more likely to remain open, making the pain felt
more intense. There are factors that may help to close the "nerve gates"
often reducing the intensity of the pain experienced, or eliminating the
pain felt entirely. These factors include;
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Cognitive Factors An individual who remains positive about their
ability to cope with pain, or uses other methods to distract themselves
from the severity of the pain may be able to effectively close the "nerve
gates," reducing the amount of pain experienced. Avoiding being under
the influence of drugs and alcohol, and using relaxation techniques such
as breathing patterns, meditations and visualizations may help effectively
close the "nerve gates," lessening the amount of pain experienced.
Emotional Factors An individual who maintains a positive
attitude and understands that pain is not always a bad thing, and
maintains a certain degree of control over themselves and their situation
is often able to effectively close the "nerve gates," reducing the intensity
of pain experienced.
Fear Tension Pain Cycle Theory
Dr. Dick in 1930 proposed the Fear Tension Pain Cycle theory in
the in laboring women. Dick- Read believed that labor was not
specifically painful, but associated by the fear the women experienced
during labor . , when a woman felt fearful during labour, would trigger
the "fight or flight" response, releasing stress hormones (catecholamines:
epinephrine, etc.) that places them in a hyper-aroused state making them
hypersensitive to pain was the observation by him. Catecholamines
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increase our heart rate, and blood pressure, slow down digestion, and
shunting blood supply away from internal organs and toward skin and
skeletal muscles  Muscular tension due to fear that increases our
experience of pain for which relaxation techniques can help to reduce the
muscle tension. The concept of the fear-tension-pain triangle is that:
when fear increases that causes, tension to increase and pain increases.
Neuromatrix theory provides a framework which tells why
selected nonpharmacologic methods of pain relief can be quite effective
for the relief of pain for the laboring woman. The theory was developed
by Ronald Melzack and represents an expansion beyond his original"gate
theory"of pain, first proposed in 1965 with P. D. Wall.
Uterine blood flow and labour
Uterine blood flow at term is 700 to 900 ml/min. During pregnancy
uterine blood flow is dependent on uterine artery perfusion pressure.
Factors that decrease uterine artery perfusion pressure or increase
uterine artery vascular resistance leads to decreased uteroplacental blood
flow.
Uterine blood flow is directly related to perfusion pressure and
inversely related to uterine vascular resistance.
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Perfusion pressure decreases due to Aortocaval compression and
supine hypotension. Syndrome, maternal haemorrhage and
hypovolemia,high epidural block with resultant hypotension.
 Increases in vascular resistance are due to Venacaval compression
Uterine contractions, performing valsalva while pushing, Oxytocin like
drugs induced uterine hypotonus. Labour pain causes increased
catecholamine release thereby resulting in increased maternal cardiac
output. Sympathetic blockade by regional analgesics may improve blood
flow to placenta but maternal hypotension decreases the uteroplacental
perfusion. There is an increased cardiac output from 12% to 34% by the
second stage of labour which are attributable to pain and apprehension
can be minimised by effective analgesia. Shnider et al found 25%
increase in plasma norepinephrine concentration due to acute stress
resulting in 50% reduction in uterine blood flow. Lederman et al
increased plasma epinephrine concentration due to pain and stress
increased the incidence of abnormal fetal heart rate patterns In
parturients.
Therefore by decreasing the circulating catecholamines and
preventing periods of hyperventilation during contractions may increase
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the uterine blood flow. Regional analgesia may decrease the blood flow
due to maternal hypotension.
LABOUR ANALGESIA AND OUTCOMES
There was inevitable selection bias, since women with long painful
labours, who had increased risk of intervention, request epidural
analgesia more likely, and those women who are high risk are actually
recommended and encouraged an epidural analgesia.
RCT are considered the gold standard for research, difficulty exists
to blind and due to problems with consent recruitment and high crossover
rates.
Effect on Cesarean section rate
In  several  trials  in  1990  s  women  randomly  assigned  to  receive
epidural analgesia or parenteral opioids found higher rates of caesarean in
epidural groups which was subjected to criticisms.
Segal and colleagues conducted metaanalysis of nine impact
studies in which 37 000. Parturients were involved and found no increase
in the cesarean  rate during  epidural analgesia.
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Cochrane review [2005] Which involved 20 studies reported
Caesarean rates not increased between women who received epidural
versus systemic analgesia for labour.
Meta- analysis by Halpern and Leighton studies[ 2005]6701
women were involved and the risk of Caesarean delivery was not
different between women who received neuraxial Analgesia and in those
who received parenteral opiod. Thorp and colleague who randomized 93
nulliparous women to receive epidural analgesia or systemic analgesia
with meperidine, 2% in meperidine group and 25% in epidural group
underwent caesarean section group.
TIMINIG OF ANALGESIA
American College of Obstetricians and Gynecologists (ACOG)
stated previously epidural analgesia, ‘when feasible, delay until the cervix
is dilated to 4–5 cm.
Regarding  the association of neuraxial analgesia with the risk of
Caesarean delivery a cause and effect question has been raised, to
whether neuraxial labour analgesia initiated early is directly responsible
for adverse labour outcomes.
Increased risk of Caesarean delivery is due to mere association.
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Several Randomized controlled trials were conducted that
compared early-labour neuraxial analgesia to systemic opioid analgesia.
Chestnut and colleague conducted two studies nulliparous women
were randomised in spontaneous labour or oxytocin augmentation group
and found that epidural analgesia initiated early and that initiated when
cervical dilation reached 5 cm, no difference in Caesarean delivery rates
were found between groups, but the validity of the results were limited
since the median cervical dilation was 3.5 cm in spontaneous women and
4.0 cm in women receiving oxytocin augmentation at the time of
initiation of analgesic.
ACOG [2006] updated Committee Opinion was published based
on these studies Entitled Analgesia and Caesarean Delivery Rates, which
stated that: ‘maternal request is a sufficient medical indication for
pain relief during labour in the absence of medical
contraindications’. The method of pain relief that women can choose
during labour should not be influenced by the fear of increased caesarean
delivery.
Royal College of Obstetricians and Gynaecologists, the Royal
College of Midwives, the Royal College of Anaesthetists, and the Royal
College of Paediatrics and Child Health stated a joint statement in 2007
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‘When women chose epidural analgesia for pain relief in labour, they
should be able to receive it in a reasonable time. This meant obstetric
units must be able to provide regional analgesia on request at all
times.’
Wang and colleagues [2009] involved more than 12 000
nulliparas in 5 years period showed Caesarean delivery rate not increased
in parturients in latent phase to receive epidural analgesia as compared
with active phase.
According to COMET trial spontaneous vaginal delivery rates is
influenced by the type of analgesia. No difference in the instrumental
vaginal delivery rate were observed before and after the availability of
neuraxial analgesia.
Second stage of labour prolongation malposition of fetus and the
loss of bearing down reflex and the loss of urge to push are the
indications to apply instrument for facilitating delivery. Systematic
reviews of randomized controlled trials wherein caesarean delivery rate
was the primary outcome neuraxial was compared with systemic opioid
analgesia, concluded neuraxial analgesia was associated with an
increased risk of instrumental vaginal delivery.
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Liberman and O Donaghue [2002] found that in metaanalysis of 17
studies women had higher instrumental delivery and longer labours.
Halpern and Leighton,[ 2002 ]the OR was 1.92.] for instrumental
vaginal delivery in epidural analgesia group versus systemic opioid
analgesia .In meta-analysis reported by Sharma and colleagues meta-
analysis by Liu and colleagues[ 2004], instrumental vaginal delivery
adjusted OR were 1.8 and 1.63, respectively.
Several confounding factors like the neuraxial analgesia density
during the second stage of labour, abdominal wall musculature relaxation
secondary to epidural local anaesthetic could result in decreased
effectiveness of maternal expulsive efforts.
Ability to coordination of expulsive efforts with uterine
contractions can also be hindered by the density of the sensory blockade
of the uterus and the birth canal.
Additionally, high concentrations of neuraxial local anaesthetic
causes relaxation of the pelvic floor musculature and leads to interference
with fetal rotation during descent and Obstetricians are urged to perform
instrumental vaginal deliveries in parturients with effective second-stage
analgesia than in parturients than those without analgesia. James and
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colleague and Olofson and colleagues noted that low dose bupivacaine 0.
125% with fentanyl 2 ?g/ml? had resulted in lower incidence of
instrumental vaginal delivery than women who received 0.25% epidural
bupivacaine.
Smedstad and Morison demonstrated 0.25% bupivacaine showed a
higher incidence of instrumental vaginal delivery when administered as a
continuous epidural infusion as compared with intermittent bolus
injections.Study by Wong and colleagues [2006] and the COMET study
demonstrated no difference in the instrumental vaginal delivery rate
between groups who received ‘low- dose’ bupivacaine/fentanyl by either
intermittent bolus or continuous infusion.
Maternal perineal trauma increases with the use of instrumental
delivery and the risk of adverse neonatal outcome is increased in, cases of
difficult midforceps delivery. It is art and science to minimize the risk of
instrumental vaginal delivery while maximizing comfort of the parturient,
tailoring to the individual needs.
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Effect on the duration of labour and labour augmentation
First stage of labour
 This parameter is assessed with conflicting results as a secondary
outcome in various  studies. Halpern and Leighton in the meta analysis of
nine impact studies and Cochrane review [2005] duration of the first
stage of labour showed no difference among women receiving epidural
labour analgesia and those systemic opioid analgesia or no analgesia,
when the parturient complains of rectal pressure, wherein full cervical
dilatation is diagnosed is likely to be at a later time in women with
effective neuraxial analgesia compared to the women with systemic
opioid analgesia. Owing to the presence of effective labour analgesia the
duration of first stage of labour may be apparently prolonged. The
duration of first stage of labour is significantly influenced by the changes
in uterine activity which are increased or decreased by neuraxial
analgesia, that may be due to the fluid bolus epidural analgesia. Fluid
bolus has been also suggested to cause a decrease in concentrations of
hormones known to had effect on the augmentation of uterine activity.
Behrens and colleagues observed that there is a decrease in the release of
prostaglandin F2 alpha in women who received epidural analgesia during
the first stage of labour, a hormone known to increase uterine activity.
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Rahm and colleagues in a prospective study demonstrated lower
plasma oxytocin concentrations 60 min after initiation of epidural
analgesia compared with parturients without epidural analgesia.Studies
demonstrate an increase in uterine activity due to acute decrease in
plasma epinephrine after initiation of neuraxial analgesia. Epinephrine
owing to its effects on ?-adrenergic receptors causes tocolysis.
Sympatholysis is associated with a rapid decrease in maternal
plasma concentrations of epinephrine.This acute decrease in maternal
epinephrine concentration with decreased beta adrenergic receptor
activation , result in increased uterine activity.
Abráo and colleagues [2009] in a randomised double blinded trial
higher incidence of uterine tachysystole and  faster onset of pain relief
and sympatholysis in the CSE group. More precipitous decrease in
maternal epinephrine concentrations, result in uterine tachysystole. Van
de Velde and colleagues also demonstrated a higher incidence of uterine
hypertonus. The studies that were associated with prolongation of the first
stage of labour no increase in adverse neonatal or maternal outcomes
owing to increased labour time.
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Second stage of labour
There may be an inhibition of urge to push but valsalva maneuvers
like maternal expulsive efforts are not impaired unless with high dense
blocks. Epidurals might block the afferent limb of the Ferugson reflex but
only theoretically. There may be a relaxation of pelvic musculature.
Halpern et al meta analysis showed second stage prolonged by 14 min in
epidural group and two fold increase in forceps delivery. It is widely
agreed that duration of second stage of labour is prolonged by effective
neuraxial analgesia. This consensus is supported by the meta- analyses of
randomized controlled trials that compared neuraxial with systemic
opioid analgesia demonstrated in a women who received neuraxial
analgesia the second stage duration was approximately 15 min longer.
The presence or absence of neuraxial analgesia is incorporated by
ACOG into their definition of second-stage dystocia, and states that the
provided the progress has been made the need for intervention
(instrumental or surgical) should not be mandated solely based on second
stage duration. Several studies suggested that provided the fetal status is
reassuring and with proper fetal head descent and the mother adequately
hydrated and pain controlled a prolonged second stage of labour does not
result in adverse maternal or fetal outcomes. Paterson and colleagues
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evaluated more than 25000 women there was no clear cut point for the
spontaneous delivery expectation in parous women with epidural
analgesia in terms of the second stage of labour, women who
spontaneously delivered an infant at ?37 weeks gestation with vertex
presentation. There was also no clear-cut point in predicting unsuccessful
spontaneous vaginal delivery in nulliparous women, due to the steady rate
of birth in this population.
The definition of prolonged second stage in women received
regional analgesia has been revised by the American College of
Obstetricians and Gynecologists[ 2003] ie more than 3 hrs in
nullipara and more than 2 hrs in multigravida Provided the fetus and
mother are both well this number is arbitrary. The risk of damage to the
neurological structures within the pelvis with longer labours is
theoretical,  and  is  difficult  to  quantify.  In  a PEOPLE trial which  is  a
randomized multi-centre controlled trial, [the Pushing Early or Pushing
Late with Epidural (PEOPLE) ] in the delayed pushing group, the rate of
spontaneous vaginal delivery was higher, duration of pushing shorter, and
rate of mid-rotational forceps lower in women as compared with
immediate pushing. Meta-analysis study [2004] of nine studies  of 72,
PEOPLE study included as one 71 concluded that delayed pushing did
not decrease the rate of instrumental vaginal delivery (RR 0.92; 95% CI
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0.84–1.01) or Caesarean delivery, but the rate of midpelvic rotational
forceps delivery was decreased (RR 0.69; 95% CI 0.55–0.87). The
delayed pushing group had longer duration of the second stage of labour,
but the neonatal outcomes are similar. Until the fetus has descended to a
lower fetal station it is preferred to delay pushing inorder to avoid
maternal exhaustion. Association between analgesia and operative
delivery is explained by the finding that women who requested analgesia
were those at increased risk for prolonged labour and operative delivery
with more likelihood to experience severe labour pain, compared with
women who had rapid and uncomplicated labours. Wuitchik and
colleagues observed that operative delivery more in  women who
experienced severe pain in the latent period. Also the rate of caesarean
delivery was almost twice in women who experienced more breakthrough
pain during low-dose bupivacaine/fentanyl epidural. Studies suggest that
there is a risk of abnormal labour and operative delivery in women who
experienced  severe pain in latent period.
Effect on the fetus and neonate
Neonatal arterial pH or APGAR scores in babies had no difference
who are born to mothers with epidurals . Hill [2003] found no deleterious
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effect on fetal heart rate Reynolds et al [1999] showed  cord PH better in
babies under epidural.
Benefits for the neonate, including a reduction in the incidence of
low APGAR scores at 5 min and in the need for naloxone are also shown
by studies. Transient alterations in fetal heart rate, particularly
bradycardias, are also reported in some studies after initiation of epidural
analgesia.
Various explanations including opioid-induced uterine
hyperstimulation and placental hypoperfusion (secondary to a fall in
maternal blood pressure and rapid onset analgesia with an ensuing rapid
fall in maternal epinephrine concentrations has been proposed.
Importance of these isolated reports is unclear clinically. However,
monitoring of the fetus remains important.
Therefore neuraxial analgesia can be initiated  individualising to
the expectant needs.
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COMPLICATIONS OF REGIONAL ANALGESIA
Hypotension
Blockage of preganglionic autonomic fibres results in
vasodilatation reduction in systemic vascular resistance and fall in
maternal blood pressure leading to fetal heart rate changes. This can be
prevented by preloading with crystalloids and maintaining lateral
position.[Danilenko –Dixon et al [1996]. Despite these one third of
women still develop hypotension [Sharma et al 1997]
Accidental dural puncture and post dural puncture headache
The incidence is 0.2 to 2 % .this is due to inadvertent advancement
of needle beyond epidural space.
 Breach in dura resuts in leakage of CSF resulting in low pressure
headache’.headache occurs 24 to 48 hrs after postural subsides in lying
down and aggravates in upright posture. Severe forms treated with
epidural blood patch and milder forms with caffeine and paracetamol.
Backache
Local tendernes 3 to 7 days in 30 % due to technical difficulty may
be  present  due  to  multiple  attempts.  Anim-Somuah  et  al  [2005]  the
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incidence of long term backache is similar in women receiving analgesia
and those who did not.
Bladder dysfunction
Bladder distension  not recognised resulting in overdistended
bladder and postpartum bladder dysfunction especially in prolonged
labour. Encouraging to void and cetheterisation can be done.
Maternal pyrexia
The temperature rise is never beyond 1 degree C and rule out
underlying cause in temperature beyond that Leighton et al [2002] and
Liberman [2002] found an association of epidural analgesia and
intrapartum fever. Pyrexia teated with hydration and supportive care.
Evaluation for neonatal sepsis not warrented.
Miscellaneous
Shivering pruritis, delayed gastric emptying.
Unintended intravascular local resulting in toxicity  and total spinal
blockage are rare and avoided by following strict protocols and risk
management strategies.
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Systemic opioid analgesia
Newborns of mothers who had neuraxial opiods there was no
difference in neonatal outcome (as assessed by Apgar scores] and
umbilical cord PH  measurements.
 No difference in long term neonatal outcome.
 Opioids block the transmission of pain-related information by
binding at presynaptic and postsynaptic receptor sites in the dorsal horn
of the spinal cord (i.e., Rexed laminae I, II, and V), and in the brainstem
nuclei, periventricular gray matter, medial thalamus. They are associated
less adverse effects than systemic use Opioid and a LA are given
epidurally, they interact synergistically to provide effective pain relief.
OPIOIDS USED TO PROVIDE EPIDURAL ANALGESIA
DURING LABOR
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Complications of Neuraxial Opioid
Pruritus
Neurotoxicity
Sensory Changes
Hypotension
Nausea and Vomiting
Respiratory Depression
Delayed Gastric Emptying
Opioid Direct fetal effects may include intrapartum effects on the
FHR as well as possible respiratory depression after delivery.
Indirect fetal effects include fetal bradycardia.
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 AGE OF PATIENT
Age Group (Years) Study Group No. ofPatients %
19 – 20 yrs 7 10%
20 – 25 33 47%
25 – 30 25 36%
>30 years 5 7%
Total 70 100%
AGE OF PATIENT
In my analysis 10% of patients in age group of 19 to 20 yrs and
majority of 47% of patients in 20to 25 yrs and 36% in 25 to 30 yrs and
only 7% in 30 yrs.
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GESTATIONAL AGE
Gestational Age No. of Patients %
>37 weeks 7 10%
38 weeks 20 28%
39 weeks 20 28%
40 weeks 15 21%
42 weeks 9 13%
Total 70 100%
GESTIONAL AGE
In my study majority of my patients in 38 and 39 weeks of
gestation 21% in 40 weeks gestation and 13% in 42 weeks gestation.
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PARITY
Parity No. of Patients %
Primi 43 61%
G2A1 7 10%
G2P1L1 / VBAC 5 8%
G2P1L1 / FTND 15 21%
Total 70 100%
PARITY
In my study primigravida constitutes 61% and second gravida with
previous normal delivery 21% and 8% of those with previous cesarean
section.
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
66
HEIGHT
Height No. of Patients %
145 – 150 13 18%
150 – 155 37 54%
156 – 160 20 28%
Total 70 100%
WEIGHT
Weight No. of Patients %
50 – 55 kg 23 34%
55 – 60 27 38%
60 – 65 20 28%
Total 70 100%
In  my  analysis  around  54%  of  patients  were  of  height  more  than
150 cm  and regarding weight 38% of them were 55 to 60 kg.
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SELECTION OF CASES
Cases No. of Patients %
No Risk 35 50%
Heart Diseases 15 21%
Anaemia 5 8%
Preeclampsia 10 13%
Gestational Diabetes 5 8%
Total 70 100%
SELECTION OF CASES
In my analysis about 50% of patients had no risk factors and 21%
of them were those with heart disease 13% were preeclampsia patients
and 8% gestational diabetes and 8% anemic patients.
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54%
39%
7%
0%
10%
20%
30%
40%
50%
60%
< 15 15 – 30 >30
IN MINUTES
ONSET OF ANALGESIA
ONSET OF ANALGESIA
Time in minutes No. of Patients %
< 15 37 54%
15 – 30 50 39%
>30 3 7%
Total 70 100%
The onset  of  analgesia  54% of  patients  had  immediate  pain  relief
within 15 minutes of initiation of main dose and 39% in 15 to 30 min and
7% in 30 minutes hence majority of them had early pain relief.
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INITIATION OF ANALGESIC TO DELIVERY INTERVAL
Time in Hrs No. of Patients %
2 to 3 hrs 8 11%
4 to 6 hrs 15 21%
6 to 8 hrs 17 24%
8 to 10 hrs 30 44
Total 70 100%
RATE OF CERVICAL DILATATION
Rate / hr. No. of Patients %
1 cm / hr 30 39%
0.5 cm / hr 10 12%
2 cm / hr 30 39%
Total 70 100%
In my analysis about 44%of patients delivered in 8 to 10 hrs of
initiation of first main dose of analgesic and 24% delivered in 6 to 8
hours 21% in4 to 6 hrs and 11 % delivered in 2 to 3 hrs with two dose of
analgesic.
Regarding cervical dilatation equal number 39% had a rate of 1cm
/hr and 2cm /hr and 12%  had 0.5 cm/hr rate of cervical dilatation.
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STAGE – I :  DURATION OF LABOUR
I stage in hrs. No. of Patients %
4 – 6 hr 3 7%
6 – 8 hr 9 12%
8 – 10 31 43%
10 – 12 27 38%
Total 70 100%
In my analysis 43% of patients had first stage of labour of 8 to 10
hrs 38% had 10 to 12 hrs of first stage of labour.
STAGE – II :  DURATION OF LABOUR
II stage in mins. No. of Patients %
30 to 60 mins 4 8%
60 to 90 mins. 18 24%
90 to 120 mins. 15 21%
> 120 mins. 33 47%
Total 70 100%
47% of patients had second stage labour beyond 120 min 24% of
them had 60 to 90min and 21% had between 90 to 120 min.
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STAGE - III
DURATION OF LABOUR
III stage in mins No. of Patients %
< 30 min 35 50%
Equal to 30 min 20 28%
> 30 min 15 22%
Total 70 100%
The duration of third stage of labour was less than 30 min in 50%
15 patients had longer than 30 min of which 1 patient had retained
placenta necessitating manual removal and 6 patient had atonic PPH
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DURATION  OF LABOUR - I STAGE
DURATION OF LABOUR – II STAGE
DURATION OF LABOUR - III STAGE
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MODE OF DELIVERY
Delivery No. of Patients %
Labour natural 10 14%
Labour natural with
Episiotomy
33 47%
Instrumental
LMC Forceps
Outlet Forceps
Vaccum
4
8
2
18.6%
Cesarean Section 15 21%
Total 70 100%
In my analysis 61% of the study group delivered labour natural
aroud 19% had instrumental delivery and 21% had cesarean delivery and
15% of control group had instrumental delivery and 24% had  and the rest
labour naturale which were similar in both groups.
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MODE OF DELIVERY
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INDICATION FOR CESAREAN
Indication No. of Patients
Failure to progress 5
Failed induction 4
Fetal Distress 3
CPD 3
Total 15
The indication for cesarean was failure to progress in 5 patient
failed induction in 4 patients fetal distress in 3 patients and cephalopelvic
disproportion in 3 patients.
THIRD STAGE COMPLICATIONS
Complications No. of Patients
Retain Placenta 1
Atonic PPH 6
Traumatic PPH 2
Total 9
Regarding third stage complication 1 patient had retained placenta
which was removed manually and 6 patients who had prolonged third
stage had atonic PPH medically managed and 2 patient had traumatic
PPH who underwent exploration and repair.
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
76
INDICATION FOR FORCEPS
Forceps No. of Patients
Failure of maternal expulsive
efforts
8
Indicated forceps 5
Fetal Distress 2
Total 15
The indications for forceps were 8 patients had failure of maternal
expulsive efforts 5 of them had indicated forceps delivery for heart
disease complicating and 2 had fetal distress and underwent forceps
delivery.
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MATERNAL COMPLICATIONS
Intrapatrum No. ofpatients Postpartum
No. of
patients
Inadequate Analgesia 5 Urinary retention 2
Dural puncture 1 Respiratory depression Nil
Venous puncture 1 Backache 2
Pruritis Nil Headache 3
Nausea & Vomiting 2 Neurological deficits Nil
Rigor 4
Hypotension 4
Regarding complications 5 patient complaint of inadequate
analgesia 1 of each patient had inadvertent dural and venous puncture and
2 patient had nausea and vomiting 4 patient had rigor 4 patient had
hypotension 2 each had urinary retention and backache and 3 had
headache and none of them had neurological deficits.These complications
were minimal and easily managed symptomatically without much
difficulty.These complications were comparable to the controls.
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FETAL OUTCOME
Outcome Intrapartum Postpartum
Early
neonatal
%
Normal alive 56 80%
Asphyxiated and
revived
10 14%
Asphyxiated not
revived (Death)
2 3%
HIE 2 3%
Fetal distress 3 4%
Hyperbilirubinemia
and revived
5 7%
In my study about 80% of babies were normal alive 14% of them
asphyxiated but revived  2 babies died in early neonatal period who were
asphyxiated but could not be revived.2 of them developed HIE in the
early neonatal period 3 babies had fetal distress diagnosed intrapartum
and 5 developed hyperbilirubinemia in early neonatal period and revived .
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APGAR 1 MIN
Score No. of  babies %
0 to 4 6 8.5%
4 to 6 6 8.5%
6 to 8 44 63%
8 to 10 14 20%
Total 70 100%
                                             APGAR (1 MIN.)
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                                           APGAR (5 MIN.)
Score No. of  babies %
0 to 4 2 3%
4 to 6 2 3%
6 to 8 10 14%
8 to 10 56 80%
Total 70 100%
About 80% had Apgar score of 8 to 10 and 14% had score of 6 to 8
and only 3% had low scores.
APGAR (5 MIN.)
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WEIGHT OF BABY
Weight in Kg No. of  babies %
< 2.5 kg 4 6%
2.5 to 2.8 kg 15 22%
2.8 to 3 kg 26 37%
>3 kg 25 35%
Total 70 100%
In my study 37% of babies were of 2.8 to 3 kg 35% of them were
of  more  than  3  kg  22% of  them were  of  weight  2.5  to  2.8  kg.and  were
comparable to controls.
WEIGHT OF THE BABY
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
82
10%
70%
15%
5%
PATIENT COMFORT
Excellent
Good
Fair
Poor
In my analysis 70% of the patients had good pain relief and 15%
had fair and only 5% complaint of poor pain relief.
Overall patients had good pain relief and  satisfaction and had good
comfort.
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Group Statistics
Group N Mean Std. Deviation
Std. Error
Mean
Age 1 70 24.80 3.545 .424
2 70 25.21 3.639 .435
T test  values:  -0.682  P=  0.496    Not  significant.
Group Statistics
Group N Mean
Std.
Deviation
Std. Error
Mean
p
Durationof
2nd stage of
labour
1 70 90.57 23.614 2.822 0.000
Significant
2 70 72.87 17.661 2.111
Group Statistics
Group N Mean
Std.
Deviation
Std. Error
Mean
P
APGAR
1 minute
1 70 6.57 1.199 .143 0.422  Not
significant
2 70 6.41 1.110 .133
APGAR
5 mts
1 70 7.66 1.102 .132 0.388
2 70 7.50 1.046 .125 Not
significant.
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Group Statistics
Group N Mean
Std.
Deviation
Std. Error
Mean
p
Birth
weight
1 70 2.884 .2801 .0335 0.096 Not
significant.
2 70 2.803 .2954 .0353
Complication * Group Crosstabulation
Group
1 2 Total
Complicati
on
0 Count 60 58 118
% within Group 85.7% 82.9% 84.3%
% of Total 42.9% 41.4% 84.3%
1 Count 10 12 22
% within Group 14.3% 17.1% 15.7%
% of Total 7.1% 8.6% 15.7%
Total Count 70 70 140
% within Group 100.0% 100.0% 100.0%
% of Total 50.0% 50.0% 100.0%
Chi  square=  0.216  P=  0.642  not  significant.
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Mode of delivery * Group Crosstabulation
Group
Total1 2
Mode of
delivery
C Count 15 17 32
% within Group 21.4% 24.3% 22.9%
% of Total 10.7% 12.1% 22.9%
I Count 13 11 24
% within Group 18.6% 15.7% 17.1%
% of Total 9.3% 7.9% 17.1%
N Count 42 42 84
% within Group 60.0% 60.0% 60.0%
% of Total 30.0% 30.0% 60.0%
Total Count 70 70 140
% within Group 100.0% 100.0% 100.0%
% of Total 50.0% 50.0% 100.0%
Chi square= 0.292  P=  0.864  Not  significant.
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DISCUSSION
 An epidural analgesia is a technique that will make a woman more
comfortable in the birthing  process. The procedure allows the patient in
fully awake state and participating in all aspects of the labour. Epidural
analgesia with an experienced anaesthetist, a dedicated obstetrician and a
well trained mid-wife can help parturients to convert the painful labour
into a less stressful event. Pain relief is considered an integral part of
labour management. Epidural analgesia is the well recognised effective
method for the pain control during labour due to irregularity of analgesia,
toxicity of local anaesthetics (LA) in some are the major limitations
Epidural analgesia also allows emergency cesarean io be proceeded with
the same. Epidural dose is often reduced in the second stage of labour  in
order to improve the maternal expulsive efforts and minimising the need
for instrumental vaginal delivery (IVD) The woman's need for epidural
analgesia (EDA) has been believed strongly related to birth-weight.
Prolonged duration of labour and instrumental delivery, that may be
observed during epidural analgesia, are due to large infants.
 This study was conducted in labour ward Institute of Social
Obstetrics Govt Kasturba Gandhi to study the maternal and perinatal
outcomes of obstetric analgesia [low dose lumbar epidural ] during
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labour.[October 2012 to November 2013] About 70 patients in active
labour [cervix effacement >50% and dilatation of >3 cm] who consented
for epidural analgesia chosen and a control group who did not receive
analgesia with similar age literacy socioeconomic status gestational age
in weeks and cervical dilatation at the beginning of study chosen.
Maximum no of patients 47% belonged to age group 20 to 25 yrs mean
age 24.8 and in the control group mean age 25. The study by Writer
Steienstra [2006] et al mean age 27 yrs the PEOPLE study [2008] mean
age 26 and standard deviation 4.2 and in Fowzia anwer et al [2008] which
also included 70 patients The mean age was 27 yrs.
In our study maximum gestational age was in 38 to 39 wks [28%]
The  studies  by  PEOPLE  [2008]  and  Writer  Stienstra  et  al  also  showed
gestational age of 39 wks 24% delivered in 6 to 8 hrs and in our study and
by PEOPLE study [2008] initiation of main dose to delivery interval was
29% and in study it was 30%.
Regarding patient comfort 70% showed good pain relief rated good
to  excellent  and  showed  satisfaction  as  compared  to  Sharma  and
colleagues [1997] 90% rated pain relief good to excellent 95% expressed
a desire for the same analgesia in future pregnancy. Fowzia Anwer study
[2008] showed 57% no pain and 21% showed little discomfort.
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In  our  study  mean  duration  of  1  st  stage  was  8  to  10  hrs  and  in
studies by Dickinson and Macdonald et al [2002] the mean duration was
8 to 9 hrs.Writer Stienstra [2006]mean duration 9 hrs. Studies by Sharma
et al [2002]first stage duration was 8 to 12 hrs.
Duration of second stage in our study group mean 90 min and in
control group 70 min In studies by Stephen Halpern leighston[1998] the
second stage was 42 min longer and by Writer Stienstra [2006] the
duration of second stage mean 90 min and in Dickinson Mcdonald study
[2002] the mean duration of second stage was 1.33 hrs and Halpern et al
[1990] metaanalysis prolonged active phase by 42 min and second stage
by 14 min.
Sleep et al [1990] stated the adverse effect of prolonged second
stage due to underlying causative factor and not on absolute duration.
Chestnut et al [1999] Thorp et al [1996]epidural analgesia prolonged
second stage with no adverse effect studies by Sharma et al [2002]
showed duration of second stage 110 min. In our study 64% of patient
needed oxytocin augmentation in studies by Sharma et al [2002] 48 % of
patients needed oxytocin augmentation PEOPLE[2008] trial showed
57.6% need for oxytocin augmentation Dickinson study[2002] showed
40% need for oytocin.
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In our study regarding the mode of delivery spontaneous vaginal
delivery was 60% and instrumental delivery 19% caesarean rate 21% in
study group and in control group 60% spontaneous vaginal delivery 16%
instrumental delivery and 24% caesarean delivery.In studies by Sharma et
al [2002] 77% had spontaneous vaginal 13% had instrumental delivery
and 10% had caesarean delivery showing no difference .Stephen Halpern
Leighton [1998] reported 8.2% caesarean rates Studies by Writer
Stienstra stated 50% spontaneous vaginal 30% instrumental and 11%
caesarean delivery. COMET trial showed 37% instrumental delivery with
conventional epidurals and 29% with low dose epidurals.Dickinson study
[2002] showed no difference in operative vaginal or caesarean rates.
Thorp et al [1993] showed increase in caesarean rates.Chestut [1998]
stated no increase in caesarean rates in nullipara. Amin somuah [2005]
based on Cochrane database review [2005]studied no difference in
caesarean rates.
 With regard to fetal outcome in our study 63% had Apgar score at
1 min 6 to 8 and 80% had Apgar score of 8 to 10 at 5 minwhich were
comparable  with  our  controls.  In  studies  by  Chestnut  et  al  [1999]  no
effect on Apgar score or Neurobehavioural scores Stephen Halpern
[1998] studies showed no difference, Mansoori et al showed low Apgarat
1 min and no difference in 5 min Apgar.
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Amin Somuah [2005 no difference in Apgar scores.
In relation to complications it was similar in both study and control
group1 patient had retained placenta, 6 patients hah Atonic PPH. 2
patients had traumatic PPH, 5 patient had inadequate analgesia, 4 patient
had hypotension, 2 had urinary retention, 2 had backache, 3 had headache
and none had neurological deficits Fowzia Anwer study [2008] showed, 2
patient with retained placenta, 2 with urinary retention and 5 patient with
inadequate analgesia. Sharma and collegues [1997] showed hypotension
in one third of patients.In studies by Liberman O Donoghue [2002] and
Richard Johanson [2002] Anim Somuah [2005] concluded no association
between epidural analgesia and new or long term backache.
In our study no influence of analgesia on breast feeding, in studies
by Wilsion et al also showed no Association.
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SUMMARY
In my study on obstetric analgesia using low dose epidural
analgesia initiated with the help of anesthesiologist majority of paturients
had effective pain relief with more than 70% had good to excellent
comfort and satisfaction and more than 80% acceptance expressed their
preference for the same in their subsequent pregnancies.The mean age 25
yrs and gestational age 39 weeks same as the controls.
 Regarding the onset of analgesia more than 55% showed rapid
onset in less than 15 min of initiation and also had longer duration of
analgesia.
Regarding duration of labour patients with epidural analgesia had
longer labours particular;y of the second stage which showed significance
with controls.M.ajority of patients delivered in 8 to 10 hrs of initiation of
main dose of analgesic which was little lengthier than the controls
Regarding mode of delivery 60% had spontaneous vaginal delivery
consistent with the controls and 19% instrumental delivery and 21%
caesarean consistent with the controls and showed no significance.
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The indication for caesarean was fetal distress in 3 patient which
was  not  due  to  the  direct  result  of  epidural  but  due  to  cord  around  the
neck and oligohydramnios.
The indication for instrumental delivery was failure of maternal
expulsive efforts in 60% that holds same for in the controls.
The  mean  Apgar  in  1  min  and  5  min  were  6  and  7  similar  to  the
controls implying epidural had no adverse effect on neonatal outcome.
The perinatal mortality was lesser in the study group compared to the
controls.
Regarding maternal complication, 2 patients had retained placenta
successfully managed with manual removal under epidural analgesia
without the need for general anesthesia and no curettage needed
subsequentl. 2 patients who had urinary retention treated with continuous
bladder drainage which occurred due to prolonged labour in one patient
with instrumental delivery and the other with traumatic PPH which
needed suturing. Other minor complications were managed
symptomatically. None of them developed long term neurological
deficits.
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CONCLUSION
In my study conducted in labour ward of ISO KGH for 70
parturients who requested and consented for epidural analgesia for pain
relief I conclude that the use of  low  dose  epidural  with  predominant
Sensory block with preservation of motor function was effective with
quick pain relief and excellent patient comfort and satisfaction and
freely movable in the first stage without major adverse effect on
maternal hemodynamics with more spontaneous vaginal delivery and the
rate of instrumental and caesarean comparable to controls but with longer
labours particularly of second stage and favourable neonatal outcomes .
Lesser perinatal mortality and few manageable maternal side effects and
proven safety to the mother and fetus in quality labour management
offered by the dedicated obstretrician with the help of an experienced
Anesthesiologist to our expectant mothers of today and tomorrow.
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LIST OF ABBREVIATION
FD - Fetal distress
FIND - Failed inclusion
FTP - Failure to progress
LN - Labour naturale
C - Cesarean
I - Instrumental
HD - Heart Diseases
AR - Asphyxiated and revived
HIE - Hypoxic Ischemic Encephalopathy
HB - Hyperbilurubinemia
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PROFORMA
No                                                    Date
Patient name                                     IP no
Age                                                   Gravida
Height                                               Weight
LMP                                                  EDD
Menstrual history
Marital history
Obstetric history
Period of gestation
Any medical comorbid condition complicating
ASA assessment
Baseline  conscious  orientation   PR  BP  VAS  SPO2  CVS  RS  of  mother
Presentation  station of presenting part
Cervical dilatation effacement uterine contractions its duration frequency
and intensity baseline fetal assessment of wellbeing including fetal heart
rate
Events recording
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Indication for epidural analgesia patient request / medical condition
Time of onset of active phase of labour
Timing of events
Start of procedure
Epidural catheter placement
Administration of drug [first dose]
Onset of sensory loss
Epidural top ups
Time
Volume
Obstetric intervention/complication
Oxytocin augmentation
Membrane ruptured
Others
Duration of labour in hrs
1 stage
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11 stage
111 stage in hrs
Total duration
Record of intranatal maternal and fetal conditions
Variable                       baseline           0 min  2 min 5 min 10 min 15 min
30 min 45 min 60min 90 min 120min
Maternal pulse rate
Blood pressure
Respiratory rate
Maternal temperature
Hydration
SPO2
VAS score
Sensory level
Fetal heart rate
Cervical dilatation and uterine contractions
Time of delivery
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Time since initiation of first dose of analgesic to delivery interval
Complication during labour
1 stage                                                      yes /no
11 stage
111 stage
Mode of delivery
Laour naturale
Labour natural with episiotomy
Instrumental
LMC forceps
Outlet forceps      its indication
Caesarean section
Indication        failure to progress             failed induction        fetal
distress      CPD              others
Any maternal complication
Yes/no                                         if yes  details
Patient comfort
Excellent/good/fair/poor
Baby                          weight                        Apgar Score  1 min  5 min
Intrapartum /postpartum/early neonatal complications
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INTRODUCTION The birth of an neonate to the painfree parturient will be the most rewarding moment
in Obstetric practice.’ The most painfull experience in a woman s life is labour. Quite unbearable is
the pain of child birth and its related agony at times is beyond description.’ The mother of yesterday is
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Multiple system like gastrointestinal,cardiovascular,respiratory,genito urinary,neuro endocrine may be
affected if pain not adequately controlled, blood flow to the placenta which may be reduced due to pain
lead to altered fetal homeostasis . These consequences are avoidable by effective...
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S.No Name Age Ip No Ht Wt Para Gesage Risk Exdila Ini-deliv I II III ln I C Complicat Bwt A1m A5M EN
1 Subha 22 19117 156 55 primi 39 4 5 8 1hr 30m LN 2.9 5 6 AR
2 Razia 25 20111 148 58 primi 38 HD 3 7 9 C/FTP PPH 2.5 8 9 N
3 MADHU 20 14800 160 60 primi 42 postdated 4 5 10 C/CPD 2.3 7 8 n
4 Sathya 25 152707 156 58 G2/ND 40 6 5 6 90m 30m outlet PPH 2.9 4 6 AR
5 Sujatha 23 18529 146 55 primi 37 4 7 10 90m 15m outlet 2.5 8 9 N
6 Gomthy 26 18663 156 58 G2/ND 42 postdated 4 4 6 30m 30m LN 3 7 8 N
7 Sasikala 22 18978 155 55 G2A1 38 HD 4 6 8 1hr 30m LN 3.2 7 9 N
8 Meena 23 19588 150 58 primi 38 Anemia 4 8 10 C/FD 3.4 7 8 N
9 Nandhini 28 19396 160 55 G2/ND 38 HD 6 8 8 2hr 15m LMC 3,8 5 7 AR
10 Famitha 22 19372 148 56 primi 40 4 6 10 c/FIND rigor 3.4 5 7 AR
11 Reshma 20 19147 152 60 primi 40 GDM 4 6 8 C/FTP hypotension 3.2 7 8 N/HB
12 Selvi 23 18279 158 65 G2/ND 42 postdated 6 6 8 2hr 30min outlet 3.6 6 7 N
13 Vasanthy 22 18647 155 62 primi 40 4 6 8 1hr 15m LN 2.9 7 8 N
14 Vanitha 26 19181 160 65 primi 38 HD 4 6 10 30m 30m LN 2.8 7 8 N
15 Geetha 28 19861 162 65 G2/lscs 38 6 4 6 30m 30m
LN/V
BAC 3 7 8 N
16 Karthiga 26 19768 156 55 primi 38 4 6 8 1hr 15m LN rigor 2.8 7 8 N/HB
17 Malar 22 19438 162 60 primi 40 HD 4 5 7 30m 15m LN 2.7 7 8 N
18 Susheela 26 19439 164 62 G2/ND 42 postdated 4 4 6 1hr 15m LN 2.9 7 8 N
19 Parvathy 25 19874 170 60 primi 40 4 7 8 90m 30m outlet hypotension 3 7 8 N
20 Anandhi 25 19974 164 58 primi 39 4 8 9 120 30m LMC 3.4 6 7 AR
21 Jayalakshmi 29 9058 148 52 primi 39 4 8 10 12om 45m outlet retainedpl 2.8 8 9 N
22 Kumari 29 11340 162 55
G2/LSC
S 38 HD 6 2 4 1HR 15M 3 8 9 N
23 Suguna 23 14514 158 56 primi 38 HD 3 6 8 C/FD 2.8 6 9 AR/
24 Madhumathi 19 14800 156 59 primi 38 mildPET 4 8 10 c/FIND 2.5 7 8 N
25 Sathya 23 15207 152 52 primi 38 HD 3 8 10 120m 15min outlet 2.6 8 9 N
26 Reena 22 16427 154 55 primi 38 3 7 10 1hr 15m LN 2,6 8 9 N
27 Saranya 18 16512 144 56 primi 39 mildPET 3 8 10 c/FD 3,4 4 5
BA/HI
E2/MA
S
28 Mahadevi 25 16550 154 55
G2/LSC
S 39 HD 6 3 6 90m 15m
LN/V
BAC 3,2 7 8 N
29 Devagi 23 16974 148 52 primi 38 Anemia 4 6 10 1hr 15m LN 2.7 8 9 N
30 Maha 23 16974 148 52
G2/LSC
S 38 4 4 6 2hr 30m outlet PPH 2.7 8 9 N
31 Dhanam 23 16534 162 60 Primi 38 GDM 4 4 6 2hr outlet N/V 3.2 8 9 N
32 Ashwini 22 17502 158 56 primi 39 GDM 4 6 8 30m 15m LN hypotension 2.8 7 8 N/HB
33 Raji 26 18056 152 56 primi 38 mildPET 4 6 10 1hr 30m LN headache 3 7 8 N
34 MAHI 28 19876 154 58 primi 39 Anemia 3 6 12 30m 15m LN headache 2.9 6 7 N
35 Rekha 22 18765 154 67 primi 38 mildPET 4 6 12 1hr 30m LN N/V 2.8 6 7 N
36 Radha 30 17685 163 60 G2/ND 40 4 5 8 30m 30m LN 3 3 4 BA/D
37 Kavitha 23 17684 154 64 G2/ND 42 postdated 6 3 6 1hr 30m LN backache 3.4 3 6 AR
38 gowri 30 17658 157 60 primi 39 4 6 8 1hr 20m LN 2.9 6 7 N
39 Akila 29 16945 158 62 PRIMI 39 4 6 8 1HR 30M LN 3 7 8 N
40 Mary 24 17682 153 56 primi 38 GDM 4 7 10 90m 30m LMC PPH 3.4 3 6 AR
41 Punitha 22 17645 160 64 primi 37 PET 4 8 10 C/FIND headche 3 4 6 AR
42 Priyanka 30 16890 165 67 primi 37 HD 4 8 10 60m 15 LN 3.2 7 8 N
43 Jansi 26 17653 156 64 primi 38 4 8 10 60m 15m LN 2,3 7 8 N
44 Preetha 26 16745 164 57 primi 39 4 8 9 30m 15m LN 2.4 7 8 N
45 Kamala 23 16543 165 54 primi 38 HD 3 8 10 90m 30m outlet 2.9 7 8 N
46 Baby 25 15687 165 64 primi 38 4 8 9 60m 15m LN 2,6 7 8 N
47 Devi 26 15890 164 67 primi 39 HD 4 8 10 90m 30 LMC PPH 2,9 4 6 A/HIE
48 Shakthi 23 17890 164 66 primi 38 4 8 10 C/FD 3 6 7 N
49 Menaka 25 16432 156 67 primi 39 4 8 9 60m 15m LN 3 7 8 N
50 Valli 22 16321 153 53 primi 37 PET 4 9 8 90m 30m outlet 3.2 6 7 N
51 Tamil 30 17685 169 67 primi 38 4 6 9 C/FTP 3 7 8 N
52 Malar 24 18976 168 66 primi 39 4 7 8 60m 30m LN 2,9 7 8 N
53 Divya 22 17654 154 67 primi 38 HD 4 7 9 90m 15m Outlet 2.9 6 7 AR
54 Jothi 19 18765 169 67 primi 39 Anemia 4 6 10 C/FTP 3.1 7 8 N
55 Bavani 25 16854 170 68 G2/ND 38 4 6 9 60m 15m LN 3 7 8 N
56 Madhu 27 18760 168 69 primi 37 GDM 4 6 8 30m 15m LN 2,8 8 9 N
57 Sasi 26 18340 169 70 primi 38 4 6 8 60m 15m LN 3,2 7 8 N
58 Rupa 30 18761 170 66 primi 39 4 7 8 C/FD 3 4 4
A/HIE/
D
59 Usha 32 19876 156 60 primi 38 HD 3 8 10 C/CPD 3.6 7 8 N
60 Kumari 30 18760 154 67 primi 39 4 7 9 60m 15m LN 3 7 8 N
61 Mayil 28 16780 170 66
G2/LSC
S 38 4 6 8 30m 14m
LN/V
BAC 2.8 7 9 N
62 Kani 22 19870 165 68 primi 39 PET 4 6 8 60m 5m LN 2.9 6 7 N
63 Purnima 30 18760 166 70 primi 38 4 6 9 C/CPD 2.8 7 9 N
64 Ramya 32 18760 170 69 primi 38 4 6 9 30m 14m LN 3 8 9 N/HB
65 Sathya 25 15689 168 79 primi 41 PET 4 8 10 C/FIND 3.2 6 7 N
66 Naadhiya 26 18760 165 67 primi 40 Anemia 4 6 8 30m 15m LN 3 7 8 AR
67 Farzana 29 16549 176 68 G2/ND 38 4 5 9 30m 30m LN 3 7 8 N
68 Divya 32 17893 145 58 G2/ND 39 PET 6 4 7 60m 15m LN 2,6 5 7 N
69 Deepa 21 15799 167 78 primi 37 PET 5 6 9 60m 30m LN 2.8 6 7 N
70 lakshmi 26 17860 154 56 primi 40 PET 3 6 7 20m 30m LN 2.4 7 8 N/HB
GROUP 2 Controls
1 Indrani 22 16678 145 54 primi 37 HD 3 8 30m 15m LN 2.8 6 7 N
2 Jansi 23 18870 156 53 primi 38 Anemia 4 9 30m 15m LN 2,9 4 6 AR
3 Sangeetha 24 16643 165 56 primi 38 4 8 30m 20m LN 2.7 7 7 N
4 Uma 26 14556 146 65 primi 39 HD 4 7 20m 20m LN 2.7 8 8 N
5 Vanathi 28 17655 176 68 G2/ND 41 PET 4 6 20m 30m LN 3 7 8 N
6 Sunitha 30 18760 156 65 G2/ND 40 5 8 30m 30m LN 3.2 6 7 N
7 Malliga 32 16687 145 54 G2/ND 40 6 9 40m 15m LN PPH 2.3 7 9 N
8 Latha 21 16445 176 56 primi 39 Anemia 4 10 40m 15m LN PPH 2,5 4 6 AR
9 Sundari 27 14557 156 65 primi 38 HD 4 7 38m 15m LN 2.7 4 4
A/HIE/
D
10 Lakshmi 30 18876 165 67 primi 39 4 8 40m 15m LN PPH 2.6 6 7 N
11 Meena 32 14553 167 68 primi 37 4 7 30m 30m LN 2.9 6 7 N
12 Gomathi 20 19987 168 69 primi 38 4 8 30m 30m LN 3 6 7 N
13 Sruthi 18 15663 169 75
G2/LSC
S 39 6 7 60m 30m
OUTLE
T 3.1 4 6 AR
14 Kamala 19 13444 145 70
G2/LSC
S 40 GDM 5 7 70m 15m LMC PPH 3.2 4 6 AR
15 Gayathri 20 18760 156 54 primi 41 4 8 45m 15m
OUTLE
T 3 6 7 N
16 Kala 21 13456 167 55 primi 40 4 9 30m 15m LN 2.9 7 8 N
17 Vimala 29 18976 176 59 primi 42 4 9 C/FD 2.8 6 7 N
18 Malathy 28 16678 145 60 primi 41 Anemia 5 9 C/FTP 2.7 8 9 N
19 Selvi 27 19870 160 63 primi 40 HD 3 6 C/FD PPH 2.6 7 8 N
20 Gowri 26 16786 156 62 primi 37 4 7 30m 20m LN 3 6 8 N
21 Mary 22 16759 158 62 primi 38 4 7 45m 20m
OUTLE
T 2.9 8 9 N
22 Baby 21 17865 167 67 primi 39 4 8 60m 20m LMC 2.8 6 7 N
23 Ramya 20 19806 158 65 G2/ND 40 6 5 30m 30m LN 2.6 4 6 N
24 Priya 27 16564 170 64 G2/ND 37 GDM 5 6 30m 30m LN 2.9 6 7 N
25 Radha 28 15432 154 61
G2/LSC
S 38 GDM 6 7 20m 20m LN 3 7 8 N
26 Sudha 24 15437 153 60 primi 39 4 8 60m 20m LN PPH 3 7 8 N
27 Saranya 31 15320 152 63 primi 38 Anemia 4 9 30m 30m LN 2.3 6 6 N
28 Preetha 22 15437 150 62 primi 38 4 8 30m 30m LN 2.4 6 7 N
29 Lavanya 21 16732 148 69 primi 38 4 9 30m 20m LN 2.6 7 8 N
30 Jeyapriya 26 15489 176 70 primi 38 HD 4 10 30m 20m LN 2.6 7 8 N
31 Akila 25 17654 158 72 primi 37 HD 4 8 30m 15m LN 2.5 7 8 N
32 Anitha 26 16754 167 73 primi 38 PET 3 8 30m 15m LN 2.7 7 8 N
33 Punitha 20 18732 145 74 primi 39 4 8 20m 15m LN 2.8 6 7 N
34 Parameshwari 21 15690 145 75 primi 39 4 6 40m 15m
OUTLE
T 3 6 7 N
35 Priyanka 20 15643 156 78 G2/ND 38 Anemia 6 8 40m 15m Outlet 2.5 7 8 N
36 Indrani 21 14421 145 56 primi 37 Anemia 4 10 45m 30m LMC 2.6 6 7 N
37 Thilaga 22 14456 156 57 primi 38 HD 4 8 60m 30m
OUTLE
T 2.8 4 6 AR
38 Usha 32 15543 167 67 primi 39 PET 4 9 60m 15m outlet 2.7 6 6 AR
39 Guna 30 16654 176 69 primi 37 4 9 C/FD PPH 3 6 7 N
40 Jaya 25 14467 156 70 primi 40 4 9 30m C/FTP 3,1 7 8 N
41 Rupa 27 14489 145 76 primi 41 PET 4 8 C/FD 2,3 6 7 N
42 Chitra 26 14432 154 54 primi 40 PET 4 9 60m 15m outlet 2.4 6 8 N
43 Sasi 28 15567 165 56 primi 42 4 9 C/CPD 2.5 6 7 N
44 Sindhu 29 16678 168 55 primi 40 4 8 30m 5m LN 2.6 7 8 N
45 Sumathi 30 14435 167 65 G2/ND 38 Anemia 6 7 60m 30m LN 3 7 8 N
46 Gomathi 22 17798 167 67
G2/LSC
S 39 HD 5 6 60m 15m LN 3 7 8 N
47 Kumari 21 15564 145 64 G2/ND 38 HD 6 8 40m 20m LN 3 7 8 N
48 Fahath 20 16660 154 62 primi 39 4 9 30m 15m LN 2.6 7 8 N
49 Nisha 25 14456 153 60 primi 37 4 9 30m 15m LN 2.7 7 8 N
50 Aithya 27 14431 152 61 primi 38 GDM 4 9 C/FTP 2.8 7 8 N/HB
51 Susan 29 14470 145 69 primi 39 GDM 4 10 C/CPD PPH 2.4 7 8 N/HB
52 Riyana 24 15567 168 76 primi 38 4 8 C/FD 2.3 7 8 N
53 Rizwana 24 14467 134 74 G2/ND 39 6 8 30m 15m LN 2.1 8 8 N
54 Madhi 27 14789 146 73
G2/LSC
S 40 6 7 30m 15m LN 2.7 8 9 N
55 Mehraj 28 15670 156 70 G2/ND 40 6 8 60m 20m LN 3.2 6 7 N
56 Banu 29 15578 145 72 G2/ND 40 Anemia 6 8 30m 15m LN 3.4 7 8 N
57 Biswana 32 14476 165 71 primi 37 Anemia 4 9 C/FD 2.6 4 4
A/HIE/
D
58 Zeenath 32 15546 154 58 primi 39 4 9 C/CPD 2.7 6 7 N
59 Fahath 21 15567 154 59 primi 37 4 9 30m 15,m LN 2.5 7 8 N
60 Aniz 19 `14465 160 67 primi 40 4 9 30m 15m LN 2.8 7 8 N
61 Fathima 18 14478 160 68 primi 38 4 9 30m 20m LN 2.9 7 8 N
62 Malar 19 14489 156 60 primi 39 4 9 30m 25m LN 3 7 8 N
63 Yasmine 20 155567 150 54 primi 38 HD 4 10 50m 15m LN 3,2 7 8 N
64 Joshwine 20 15342 165 53 primi 40 HD 4 10 60m 20m LMC 3 4 6 AR
65 Anitha 21 15346 165 52 primi 38 4 8 C/FTP 2.8 6 7 N
66 Lalitha 23 134562 145 58 primi 39 4 9 C/CPD PPH 2,3 6 7 N
67 Hillypushpam 24 17689 165 54 primi 40 4 8 C/CPD 2.9 6 7 N
68 Durgadevi 26 15638 156 59 primi 37 4 9 C/FD 2.8 4 6
A/HIE/
RDS
69 Dhanam 30 15647 165 70 G2/ND 38 6 9 30m 15m LN 3 8 8 N
70 Regana 32 15980 154 65 G2/ND 38 PET 6 9 30m 20m LN 3 8 9 N
